The noble Baroness is quite right—it is in spite of our being in the European Union. This precautionary principle regulation increasingly affects international pharmaceutical companies, which have said to me that it is important that we should not allow much more of that or we will be a less friendly place for innovation.
European Union (Withdrawal Agreement) Bill
Proceeding contribution from
Viscount Trenchard
(Conservative)
in the House of Lords on Wednesday, 15 January 2020.
It occurred during Committee of the Whole House (HL)
and
Debate on bills on European Union (Withdrawal Agreement) Bill.
Type
Proceeding contribution
Reference
801 c806
Session
2019-21
Chamber / Committee
House of Lords chamber
Subjects
Librarians' tools
Timestamp
2024-04-26 20:52:07 +0100
URI
http://hansard.intranet.data.parliament.uk/Lords/2020-01-15/20011540000151
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2020-01-15/20011540000151
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2020-01-15/20011540000151